Department of Biology, The Catholic University of America, Washington, DC, United States of America.
RNA Molecular Biology Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, United States of America.
BMC Mol Cell Biol. 2023 Aug 17;24(1):26. doi: 10.1186/s12860-023-00488-z.
Heterogeneous nuclear ribonucleoprotein K (HNRNPK) regulates pre-mRNA processing and long non-coding RNA localization in the nucleus. It was previously shown that shuttling of HNRNPK to the cytoplasm promotes cell proliferation and cancer metastasis. However, the mechanism of HNRNPK cytoplasmic localization, its cytoplasmic RNA ligands, and impact on post-transcriptional gene regulation remain uncharacterized.
Here we show that the intermediate filament protein Keratin 19 (K19) directly interacts with HNRNPK and sequesters it in the cytoplasm. Correspondingly, in K19 knockout breast cancer cells, HNRNPK does not localize in the cytoplasm, resulting in reduced cell proliferation. We comprehensively mapped HNRNPK binding sites on mRNAs and showed that, in the cytoplasm, K19-mediated HNRNPK-retention increases the abundance of target mRNAs bound to the 3' untranslated region (3'UTR) at the expected cytidine-rich (C-rich) sequence elements. Furthermore, these mRNAs protected by HNRNPK in the cytoplasm are typically involved in cancer progression and include the p53 signaling pathway that is dysregulated upon HNRNPK knockdown (HNRNPK KD) or K19 knockout (KRT19 KO).
This study identifies how a cytoskeletal protein can directly regulate gene expression by controlling the subcellular localization of RNA-binding proteins to support pathways involved in cancer progression.
异质核核糖核蛋白 K(HNRNPK)调节前体 mRNA 处理和长非编码 RNA 在核内的定位。先前的研究表明,HNRNPK 向细胞质的穿梭促进了细胞增殖和癌症转移。然而,HNRNPK 细胞质定位的机制、其细胞质 RNA 配体以及对转录后基因调控的影响仍未被阐明。
在这里,我们显示中间丝蛋白角蛋白 19(K19)直接与 HNRNPK 相互作用,并将其隔离在细胞质中。相应地,在 K19 敲除的乳腺癌细胞中,HNRNPK 不会定位在细胞质中,导致细胞增殖减少。我们全面绘制了 HNRNPK 在 mRNA 上的结合位点,并表明在细胞质中,K19 介导的 HNRNPK 保留增加了与预期胞嘧啶丰富(C-rich)序列元件结合的靶 mRNA 的丰度。此外,这些在细胞质中受 HNRNPK 保护的 mRNA 通常与癌症进展有关,包括 p53 信号通路,该通路在 HNRNPK 敲低(HNRNPK KD)或 K19 敲除(KRT19 KO)时失调。
这项研究确定了一种细胞骨架蛋白如何通过控制 RNA 结合蛋白的亚细胞定位来直接调节基因表达,以支持与癌症进展相关的途径。